About MedLumics
MedLumics is a company based in Madrid (Spain) founded in 2009. MedLumics has raised $62.81 million across 6 funding rounds from investors including Edmond de Rothschild, Kurma Partners and Andera Partners. MedLumics operates in a competitive market with competitors including SpectraWAVE, NinePoint Medical, DermaSensor, SciBase and DAMAE Medical, among others.
- Headquarter Madrid, Spain
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$62.81 M (USD)
in 6 rounds
-
Latest Funding Round
$52.71 K (USD), Grant
Apr 30, 2022
-
Investors
Edmond de Rothschild
& 11 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of MedLumics
Unlock access to complete
Unlock access to complete
Funding Insights of MedLumics
MedLumics has successfully raised a total of $62.81M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $52.71 thousand completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MedLumics
MedLumics has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Edmond de Rothschild, Kurma Partners and Andera Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Capital is provided to firms for growth, buyouts, and acquisitions.
|
Locked | Locked | Locked |
Investor details for MedLumics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MedLumics
Investment portfolio details for MedLumics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MedLumics
Detailed financials for MedLumics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medlumics Comparisons
Peer comparison for MedLumics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MedLumics
MedLumics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SpectraWAVE, NinePoint Medical, DermaSensor, SciBase and DAMAE Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
|
|
| Locked | Locked | Locked |
Optical coherence tomography systems for tissue microstructure imaging are developed.
|
|
| Locked | Locked | Locked |
Handheld diagnostic device for skin cancer lesions is developed.
|
|
| Locked | Locked | Locked |
Point-of-care device for malignant melanoma detection is provided.
|
|
| Locked | Locked | Locked |
Non-invasive 3D imaging devices for skin cancer diagnostics are developed.
|
Detailed competitors of MedLumics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medlumics
Complete news archive for MedLumics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MedLumics
MedLumics was founded in 2009 and raised its 1st funding round 2 years after it was founded.
MedLumics is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
MedLumics is a funded company, having raised a total of $62.81M across 6 funding rounds to date.
MedLumics was founded in 2009 in Madrid, Spain, as a developer of optical coherence tomography for biological tissue imaging. Infrared light is employed to produce noninvasive sectional images with micrometer resolution, enabling virtual biopsies. The platform serves as a point-of-care diagnostic solution, with applications in skin disease management. The Nitid product, weighing about 3kg, is marketed under CE certification by sister company DermaLumics in the dermatology sector.
MedLumics's top competitors include DermaSensor, NinePoint Medical and SciBase.
MedLumics has 12 investors. Key investors include Edmond de Rothschild, Kurma Partners, Andera Partners, European Union, and CDTI.